CClinicalTrials.gg
CompletedNCT00588211Updated Sep 16, 2022

Measurement of Cancer-Related Risk Perception in Smokers

An observational study in Cancer Related-Risks, Risk Perception and Survey, sponsored by Memorial Sloan Kettering Cancer Center. Completed at 4 sites in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-09-16.

Sponsored by Memorial Sloan Kettering Cancer Center · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
1,514
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to develop an accurate way of measuring people's thoughts about cancer risk. The researchers at the Queens Hospital Center, Memorial Sloan-Kettering Cancer Center and Adelphi University are working together to design a new measure. Findings from this study will help us find new ways to help people avoid cancer.

Read the detailed description

The goal of the study is to develop and provide initial evidence for the reliability and validity of a measure of cancer-related risk perception. As such, the primary outcomes of the study will be initial construct validity (convergent validity and discriminant validity) of the proposed scale as evidenced by correlations of this test with other tests that vary in the degree of association to the proposed construct of cancer-related risk perception. It is anticipated that the cancer-related risk perception scale will correlate most highly (.50-.60) with measures of tobacco and environmental risk exposures, readiness to quit smoking, and family cancer history.

02

Conditions studied

  • Cancer Related-Risks
  • Risk Perception
  • Survey
  • Focus Group

Keywords

  • Cancer related-Risks
  • Risk Perception
  • Survey
  • Focus Group
  • Smoking cessation
  • tobacco
03

In context

Lead sponsor

Memorial Sloan Kettering Cancer Center is the lead sponsor of 1,930 studies on the registry; 328 are open to participants now.

Of its 129 completed or terminated interventional studies of FDA-regulated products, 66 (51%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

  • clinic patients Queens Hospital Center
  • students participants from Adelphi University

Inclusion criteria

  • Subject must be >= to 18 years of age
  • For recruitment at Adelphi University: Speak English
  • For recruitment at Queens Hospital Center: Speak English
  • For recruitment at Queens Hospital Center: Must be a Queens Hospital Center Patient

Exclusion criteria

Exclusion Criteria:

  • Patients who have a history of colorectal cancer at the Queens Hospital Center
  • Patients who cannot give informed consent
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
1,514 participants (actual)

Groups and cohorts

  • 1

    We will recruit fifteen New York University College of Dentistry (NYUCD) clinic patients who report current tobacco use.

    Behavioral: Interviews

  • 2

    Second, we will recruit thirty dental clinic smokers (10 per day for 3 days) from the NYUCD waiting room.

    Behavioral: focus group

  • 3

    Third, we will survey 200 student participants from Adelphi University.

    Behavioral: Survey

  • 4

    Queens Hospital Center with 800 patients.

    Behavioral: Survey

Interventions

  • BehavioralInterviews

    45-minute individual interviews after the conclusion of their dental appointment

  • Behavioralfocus group

    A focus group of the preliminary cancer-related risk perception item pool.

  • BehavioralSurvey

    Quantitative item analysis of the final item pool.

  • BehavioralSurvey

    A second confirmatory factor analysis.

06

What researchers measure

Primary outcomes

  1. Develop a comprehensive "blueprint," or description of the cancer-related risk perception construct; to use it to generate a cancer-related risk perception item pool; conduct an analysis of the generated items

    Time frame: 3 years

Secondary outcomes

  1. to establish initial evidence for scale reliability and validity

    Time frame: 3 years

07

Study locations

4 sites
  • Queens Hospital Center
    Jamaica, New York 11432, United States
  • New York University, College of Dentistry
    New York, New York 10010, United States
  • Memorial Sloan-Kettering Cancer Center
    New York, New York 10065, United States
  • Adelphi University
    New York, New York 11013, United States
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 16, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00588211
Lead sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
National Cancer Institute (NCI), Adelphi University, Queen's Hospital Center
Responsible party
Sponsor
First posted
Jan 8, 2008
Start date
Sep 2001
Primary completion
Sep 13, 2022
Completion
Sep 13, 2022
Last update
Sep 16, 2022

Study contacts

Jennifer L Hay, PhD
principal investigator · Memorial Sloan Kettering Cancer Center
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion